ClinicalTrials.Veeva

Menu

Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy

K

Kaplan Medical Center

Status

Unknown

Conditions

Ovarian Function Insufficiency

Treatments

Procedure: Salpingectomy or Fimbriectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT01782807
kmc0029-11

Details and patient eligibility

About

The impact of Hysterectomy with preservation of the ovaries on ovarian function has long been controversial. studies have shown conflicting data regarding ovarian function after simple Hysterectomy.

In recent years, there is a growing evidence that Salpingectomy or Fimbriectomy may have preventive value reducing Ovarian and Primary Peritoneal carcinoma, but the safety and the consequences regarding ovarian function have yet to be established.

The aim of this study is to evaluate ovarian function after Hysterectomy alone Vs. Hysterectomy combined with salpingectomy or fimbriectomy

Enrollment

60 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women undergoing Hysterectomy for Benign In dication (eg. Uterus Myomatous) before menopause

Exclusion criteria

  • Menopause
  • known or suspected malignancy

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Hysterectomy
No Intervention group
Description:
Hysterectomy without oophorectomy or salpingectomy
Hysterctomy with salpingectomy or fimbriectomy
Experimental group
Description:
Salpingectomy or Fimbriectomy
Treatment:
Procedure: Salpingectomy or Fimbriectomy

Trial contacts and locations

1

Loading...

Central trial contact

Yael Naaman, MD; Alon Ben- Arie, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems